Skip to main content

Advertisement

Log in

Gastrointestinal and Hepatic Manifestations of Rheumatoid Arthritis

  • Review
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Rheumatoid arthritis (RA), characterized by inflammation of the synovium and surrounding structures, has a prevalence of 0.5–1%. Rheumatoid vasculitis (RV) is an inflammatory condition of the small- and medium-sized vessels that affects up to 5% of patients with RA with intestinal involvement in 10–38% of these cases. Clinically apparent RV of the gastrointestinal (GI) tract, while rare, is often catastrophic, resulting in ischemic ulcers and bowel infarction. Vasculitis of the colon may present as pancolitis clinically similar to ulcerative colitis. Rectal biopsies that include submucosal vessels are positive for vasculitis in up to 40% of cases. Abnormal esophageal motility in RA may result in heartburn and dysphagia. Chronic atrophic gastritis may be associated with hypergastrinemia and hypo- or achlorhydria, promoting small bowel bacterial overgrowth. RA is the most common cause of secondary amyloidosis with GI symptoms in 22% of affected patients. Although amyloid is usually found in the liver, it is rarely evident clinically. Felty’s syndrome occurs in less than 1% of patients with RA and is characterized by neutropenia and splenomegaly. The liver may be involved with portal fibrosis or nodular regenerative hyperplasia. Liver histology is abnormal in 92% of RA patients at autopsy, although the changes are usually mild without associated hepatomegaly. Drug-induced liver disease may occur with aspirin, sulfasalazine, and methotrexate. Significant liver damage is rare if the drug is discontinued or the patient is properly monitored. RA can affect both the GI tract and the liver; changes are usually mild except with RV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmune Rev. 2005;4:130–136.

    Article  Google Scholar 

  2. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthr Rheum. 2010;62:2569–2581.

    Article  Google Scholar 

  3. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum. 1988;31:315–324.

    Article  CAS  Google Scholar 

  4. Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21:33–36.

    CAS  PubMed  Google Scholar 

  5. Genta MS, Genta RM, Gabay C. Systemic rheumatoid vasculitis: a review. Semin Arthr Rheum. 2006;36:88–98.

    Article  Google Scholar 

  6. Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine. 1981;60:288–297.

    Article  CAS  PubMed  Google Scholar 

  7. Geirsson AJ, Sturfelt G, Truedsson L. Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. Ann Rheum Dis. 1987;46:727–733.

    Article  CAS  PubMed  Google Scholar 

  8. Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct? Rheumatology. 2004;43:920–923.

    Article  CAS  PubMed  Google Scholar 

  9. Silman AJ, Newman J, MacGregor AJ. Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins. Arthr Rheum. 1996;39:732–735.

    Article  CAS  Google Scholar 

  10. Voskuyl AE, Zwinderman AH, Westedt ML, Vandenbroucke JP, Breedveld FC, Hazes JMW. Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis. 1996;55:190–192.

    Article  CAS  PubMed  Google Scholar 

  11. Lindsay MK, Tavadia HB, Whyte AS, Lee P, Webb J. Acute abdomen in rheumatoid arthritis due to necrotizing arteritis. Br Med J. 1973;2:592–593.

    Article  CAS  PubMed  Google Scholar 

  12. Bienenstock H, Minick CR, Rogof B. Mesenteric arteritis and intestinal infarction in rheumatoid disease. Arch Intern Med. 1967;119:359–364.

    Article  CAS  PubMed  Google Scholar 

  13. Babian M, Nasef S, Soloway G. Gastrointestinal infarction as a manifestation of rheumatoid vasculitis. Am J Gastroenterol. 1998;93:119–120.

    Article  CAS  PubMed  Google Scholar 

  14. Achkar AA, Stanson AW, Johnson M, et al. Rheumatoid vasculitis manifesting as intra-abdominal hemorrhage. Mayo Clin Proc. 1995;70:565–569.

    Article  CAS  PubMed  Google Scholar 

  15. Van Laar JM, Smit VT, de Beus WM, Collee G, Jansen EH, Breedveld FC. Rheumatoid vasculitis presenting as appendicitis. Clin Exp Rheumatol. 1998;16:736–738.

    PubMed  Google Scholar 

  16. Kuehne SE, Gauvin GP, Shortsleeve MJ. Small bowel stricture caused by rheumatoid vasculitis. Radiology. 1992;184:215–216.

    CAS  PubMed  Google Scholar 

  17. Mizuno K, Ikeda K, Saida Y, Takenaka R, Shibata M, Takeuchi T. Hepatic hemorrhage in malignant rheumatoid arthritis. Am J Gastroenterol. 1996;91:2624–2625.

    CAS  PubMed  Google Scholar 

  18. Hocking WG, Lasser K, Ungerer R, Bersohn M, Palos M, Spiegel T. Spontaneous hepatic rupture in rheumatoid arthritis. Arch Intern Med. 1981;141:792–794.

    Article  CAS  PubMed  Google Scholar 

  19. Dahlberg PJ, Lockhart JM, Overholt EL. Diagnostic studies for systemic necrotizing vasculitis. Sensitivity, specificity, and predictive value in patients with multisystem disease. Arch Intern Med. 1989;149:161–165.

    Article  CAS  PubMed  Google Scholar 

  20. Tribe CR, Scott DGI, Bacon PA. Rectal biopsy in the diagnosis of systemic vasculitis. J Clin Pathol. 1981;34:843–850.

    Article  CAS  PubMed  Google Scholar 

  21. Warren CPM. Arthritis associated with salmonella infections. Ann Rheum Dis. 1970;29:483–487.

    Article  CAS  PubMed  Google Scholar 

  22. Berden JH, Muyntjens HL, Van de Putte LB. Reactive arthritis associated with Campylobacter jejuni enteritis. Br Med J. 1976;i:380–381.

    Google Scholar 

  23. Drenick EJ, Bassett LW, Stanley TM. Rheumatoid arthritis associated with jejunoileal bypass. Arthr Rheum. 1984;27:1300–1305.

    Article  CAS  Google Scholar 

  24. Bjarnason I, Williams P, So A, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of nonsteroidal anti-inflammatory drugs. Lancet. 1984;ii:1171–1174.

    Article  Google Scholar 

  25. Segal AW, Isenberg DA, Hajiprouso V, Tolfree S, Clark J, et al. Preliminary evidence for gut involvement in the pathogenesis of rheumatoid arthritis? Br J Rheumatol. 1986;25:162–166.

    Article  CAS  PubMed  Google Scholar 

  26. Podas T, Nightingale JMD, Oldham R, Roy S, Sheehan NJ, Mayberry JF. Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone. Postgrad Med J. 2007;83:128–131.

    Article  CAS  PubMed  Google Scholar 

  27. Marcolongo R, Bayeli PF, Montagnani M. Gastrointestinal involvement in rheumatoid arthritis: a biopsy study. J Rheum. 1979;6:163–173.

    CAS  PubMed  Google Scholar 

  28. Bjarnason I, Hopkinson H, Zanelli G, Prouse P, Smethurst P, et al. Treatment of non-steroidal anti-inflammatory drug induced enteropathy. Gut. 1990;31:777–780.

    Article  CAS  PubMed  Google Scholar 

  29. O’Farrelly C, Marten D, Melcher D, et al. Association between villous atrophy in rheumatoid arthritis and a rheumatoid factor and gliadin-specific IgG. Lancet. 1988;ii:819–822.

    Article  Google Scholar 

  30. Francis J, Carty JE, Scott BB. The prevalence of celiac disease in rheumatoid arthritis. Eur J Gastroenterol Hepatol. 2002;14:1355–1356.

    Article  PubMed  Google Scholar 

  31. Hvatum M, Kanerud L, Hallgren R, Brandtzaeg P. The gut-joint axis: cross reactive food antibodies in rheumatoid arthritis. Gut. 2006;55:1240–1247.

    Article  CAS  PubMed  Google Scholar 

  32. Pillemer SR, Reynolds WJ, Yoon SJ, Perera M, Newkirk M, Klein M. IgA related disorders in rheumatoid arthritis. J Rheumatol. 1987;14:880–886.

    CAS  PubMed  Google Scholar 

  33. Teitsson I, Withrington RH, Seifert MH, Valdimarsson H. Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor. Ann Rheum Dis. 1984;43:673–678.

    Article  CAS  PubMed  Google Scholar 

  34. Ludviksson BR, Jonsson T, Erlendsson K, Sigfusson A. Disease manifestations in patients with isolated elevation of IgA rheumatoid factor. Scand J Rheumatol. 1992;21:1–4.

    Article  Google Scholar 

  35. Kanerud L, Engstrom GN, Tarkowski A. Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis. Ann Rheum Dis. 1995;54:256–262.

    Article  CAS  PubMed  Google Scholar 

  36. Franks AST. Temporomandibular joint in adult rheumatoid arthritis. A comparative evaluation of 100 cases. Ann Rheum Dis. 1969;28:139–145.

    Article  CAS  PubMed  Google Scholar 

  37. Lindquist C, Santavirta S, Sandelin J, et al. Dysphagia and micrognathia in a patient with juvenile rheumatoid arthritis. Clin Rheumatol. 1986;5:410–415.

    Article  Google Scholar 

  38. Sun DCH, Roth SH, Mitchell CS, England DW. Upper gastrointestinal disease in rheumatoid arthritis. Dig Dis Sci. 1974;19:405–410.

    Article  CAS  Google Scholar 

  39. John V, Stirling AJ, Matthews HR. Rheumatoid stricture of oesophagus. Br Med J. 1978;1:479.

    Article  CAS  PubMed  Google Scholar 

  40. Malone ED, McCormick PA, Daly L, et al. Peptic ulcer in rheumatoid arthritis—intrinsic or related to drug therapy? Br J Rheumatol. 1986;25:342–344.

    Article  CAS  PubMed  Google Scholar 

  41. Goggins PM, Collins DA, Jazrawi RP, et al. Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis. Gut. 1993;34:1677–1680.

    Article  Google Scholar 

  42. Doube A, Collins AJ. Editorial: is the gut intrinsically abnormal in rheumatoid arthritis? Ann Rheum Dis. 1988;47:617–619.

    Article  CAS  PubMed  Google Scholar 

  43. Henriksson AEK, Blomquist L, Nord CE, Midtvedt T, Uribe A. Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Ann Rheum Dis. 1993;52:503–510.

    Article  CAS  PubMed  Google Scholar 

  44. De Witte TJ, Geerdink PJ, Lamers CB, Boerbooms AM, van der Korst JK. Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis. Ann Rheum Dis. 1979;38:14–17.

    Article  PubMed  Google Scholar 

  45. Rowden DR, Taylor IL, Richter JA, Pinals RS, Levine RA. Is hypergastrinaemia associated with rheumatoid arthritis? Gut. 1978;19:1064–1067.

    Article  CAS  PubMed  Google Scholar 

  46. Rooney PJ, Vince J, Kennedy AC, Webb J, Lee P, et al. Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J. 1973;1:752–753.

    Article  Google Scholar 

  47. Rooney PJ, Kennedy AC, Gray GH, Sturrock RD, Buchanan KD, Dick WC. Serum immunoreactive gastrin in rheumatoid arthritis. Ann Rheum Dis. 1976;35:246–250.

    Article  CAS  PubMed  Google Scholar 

  48. Henriksson K, Uvnas-Moberg K, Nord CE, Johansson C, Gullberg R. Gastrin, gastric acid secretion, and gastric microflora in patients with rheumatoid arthritis. Ann Rheum Dis. 1986;45:475–483.

    Article  CAS  PubMed  Google Scholar 

  49. Partridge REH, Duthie JJR. Incidence of macrocytic anaemia in rheumatoid arthritis. Br Med J. 1963;1:89–91.

    Article  CAS  PubMed  Google Scholar 

  50. Snook JA, De Silva HJ, Jewell DP. The association of autoimmune disorders with inflammatory bowel disease. Quart J Med. 1989;72:835–840.

    CAS  PubMed  Google Scholar 

  51. Adachi Y, Hinoda Y, Takahashi H, et al. Rheumatoid arthritis associated with ulcerative colitis. J Gastroenterol. 1996;31:590–595.

    Article  CAS  PubMed  Google Scholar 

  52. Toussirot E, Wendling D. Crohn’s disease associated with seropositive rheumatoid arthritis. Clin Exp Rheumatol. 1997;15:307–311.

    CAS  PubMed  Google Scholar 

  53. Burt RW, Berenson MM, Samuelson CO, et al. Rheumatoid vasculitis of the colon presenting as pancolitis. Dig Dis Sci. 1983;28:183–188.

    Article  CAS  PubMed  Google Scholar 

  54. Ryutaro M, Masaru M, Tetsuya T, Yoshiro O, Ken Y, Tetsuo A. A case of pneumatosis cystoides intestinalis associated with rheumatoid arthritis, Sjögren’s syndrome, and abdominal free air. J Jpn Surg Assoc. 2004;65(5):1285–1289.

    Google Scholar 

  55. Seaman WE, Plotz PH, Ishak KG. Aspirin-induced hepatotoxicity in patients with RA or systemic lupus erythematosus (SLE). Arthr Rheum. 1974;17:325.

    CAS  Google Scholar 

  56. Rich RR, Johnson JS. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthr Rheum. 1973;16(1):1–9.

    Article  CAS  Google Scholar 

  57. Miller JJ, Weissman DB. Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis. Arthr Rheum. 1976;19:115–118.

    Article  Google Scholar 

  58. Athreya BH, Moser G, Cecil HS, Myers AR. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study. Arthr Rheum. 1975;18:347–352.

    Article  CAS  Google Scholar 

  59. Bernstein BH, Singsen BH, King KK, Hanson V. Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis. Am J Dis Child. 1977;131:659–663.

    CAS  PubMed  Google Scholar 

  60. Caspi D, Fuchs D, Yaron M. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis. Ann Rheum Dis. 1992;51:275–276.

    Article  CAS  PubMed  Google Scholar 

  61. Losek JD, Werlin SL. Sulfasalazine hepatotoxicity. Am J Dis Child. 1981;135:1070–1071.

    CAS  PubMed  Google Scholar 

  62. West SG. Methotrexate hepatotoxicity. Rheum Dis Clin North Am. 1997;23:883–915.

    Article  CAS  PubMed  Google Scholar 

  63. Kremer JM, Alarcon GS, Lightfoot RW, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. Am College Rheumatol Arthr Rheum. 1994;37(3):316–328.

    CAS  Google Scholar 

  64. Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine. 1991;70:246–256.

    Article  CAS  PubMed  Google Scholar 

  65. Kuroda T, Tanabe N, Sakatsume M, et al. Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheum. 2002;21:123–128.

    Article  CAS  Google Scholar 

  66. Kobayashi H, Tada S, Fuchigami T, et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol. 1996;35:44–49.

    Article  CAS  PubMed  Google Scholar 

  67. Fushimi T, Takahashi Y, Kashima Y, et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid. 2005;12:48–53.

    Article  PubMed  Google Scholar 

  68. Babb RB, Alarcon-Segovia D, Dressner GR, McPherson JR. Malabsorption in rheumatoid arthritis: an increased complication caused by amyloidosis. Arthr Rheum. 1967;10:63–70.

    Article  CAS  Google Scholar 

  69. Pettersson T, Wegelius O. Biopsy diagnosis of amyloidosis in rheumatoid arthritis. Malabsorption caused by intestinal amyloid deposits. Gastroenterology. 1972;62:22–27.

    CAS  PubMed  Google Scholar 

  70. Shimada Y, Tosa H, Terasawa K, Tanaka M. A gastrointestinal endoscopic study on secondary amyloidosis complicating rheumatoid arthritis. Dig Endosc. 1992;4:37–42.

    Article  Google Scholar 

  71. Klem PJ, Sorsa S, Happonen RP. Fine-needle aspiration biopsy from subcutaneous fat: an easy way to diagnose secondary amyloidosis. Scand J Rheumatol. 1987;16:429–431.

    Article  Google Scholar 

  72. Oishi K, Wada J, Nagake Y, et al. Fatal pancreatitis associated with systemic amyloidosis in a rheumatoid arthritis patient. J Med. 2000;31:303–310.

    CAS  PubMed  Google Scholar 

  73. Shimoyama M, Ohtahara A, Fukui H, et al. Acute secondary gastrointestinal amyloidosis in a patient with rheumatoid arthritis. Am J Med Sci. 2003;326(3):145–147.

    Article  PubMed  Google Scholar 

  74. Kuroda T, Otaki Y, Sato H, et al. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with infliximab. Rheumatol Int. 2008;28:1155–1159.

    Article  PubMed  Google Scholar 

  75. Sienknecht CW, Urowitz MB, Pruzanski W, Stein HB. Felty’s syndrome: clinical and serological analysis of 34 cases. Ann Rheum Dis. 1977;36:500–507.

    Article  CAS  PubMed  Google Scholar 

  76. Thorne C, Urowitz MB, Wanless I, Roberts E, Blendis LM. Liver disease in Felty’s syndrome. Am J Med. 1982;73:35–40.

    Article  CAS  PubMed  Google Scholar 

  77. Cohen ML, Manier JW, Bredfeldt JE. Sinusoidal lymphocytosis of the liver in Felty’s syndrome with a review of the liver involvement in Felty’s syndrome. J Clin Gastroenterol. 1989;11:92–94.

    Article  CAS  PubMed  Google Scholar 

  78. Blendis LM, Ansell ID, Jones KL, Hamilton E, Williams R. Liver in Felty’s syndrome. Br Med J. 1970;1:131–135.

    Article  CAS  PubMed  Google Scholar 

  79. Cohen MD, Ginsburg WW, Allen GL. Nodular regenerative hyperplasia of the liver and bleeding esophageal varices in Felty’s syndrome. A case report and literature review. J Rheumatol. 1982;9:716–718.

    CAS  PubMed  Google Scholar 

  80. Tiger LH, Gordon MH, Erhlich GE, Shapiro B. Liver enlargement demonstrated by scintigraphy in rheumatoid arthritis. J Rheumatol. 1976;3:15–20.

    CAS  PubMed  Google Scholar 

  81. Schaller J, Beckwith B, Wedgwood RJ. Hepatic involvement in juvenile rheumatoid arthritis. J Pediatrics. 1970;77:203–210.

    Article  CAS  Google Scholar 

  82. Haskard DO, Higgins CS, Temple LN, Currey HLF. Spontaneous rupture of the spleen in rheumatoid arthritis. Ann Rheum Dis. 1983;42:4111–4114.

    Google Scholar 

  83. Cockel R, Kendall MJ, Becher JF, Hawkins CF. Serum biochemical values in rheumatoid disease. Ann Rheum Dis. 1971;30:166–170.

    Article  CAS  PubMed  Google Scholar 

  84. Rau R, Pfenninger K, Boni A. Liver function tests and liver biopsies in patients with rheumatoid arthritis. Ann Rheum Dis. 1975;34:198–199.

    Article  CAS  PubMed  Google Scholar 

  85. Fernandes L, Sullivan S, McFarlane IG, et al. Studies on the frequency and pathogenesis of liver involvement in rheumatoid arthritis. Ann Rheum Dis. 1979;38:501–506.

    Article  CAS  PubMed  Google Scholar 

  86. Spooner RJ, Smith DH, Bedford D, Beck PR. Serum gamma-glutamyltransferase and alkaline phosphatase in rheumatoid arthritis. J Clin Pathol. 1983;35:638–641.

    Article  Google Scholar 

  87. Akesson A, Berglund K, Karlsson M. Liver function in some common rheumatic diseases. Scand J Rheumatol. 1980;9:81–88.

    Article  CAS  PubMed  Google Scholar 

  88. Webb J, Whaley K, MacSween RNM, Nuki G, Dick WC, Buchanan WW. Liver disease in rheumatoid arthritis and Sjögren’s syndrome. Ann Rheum Dis. 1975;34:70–81.

    Article  CAS  PubMed  Google Scholar 

  89. Aida S. Alkaline phosphatase isoenzyme activities in rheumatoid arthritis: hepatobiliary enzyme dissociation and relation to disease activity. Ann Rheum Dis. 1993;52:511–516.

    Article  CAS  PubMed  Google Scholar 

  90. Kendall MJ, Cockel R, Becker J, Hawkins CF. Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? Ann Rheum Dis. 1980;29:537–540.

    Article  Google Scholar 

  91. Nanke Y, Kotake S, Akama H, Kamatani N. Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients. Clin Rheumatol. 2002;21:198–202.

    Article  PubMed  Google Scholar 

  92. Kendall MJ, Farr M, Bold AM, Hawkins CF. 5′-nucleotidase in the serum and synovial fluid of patients with rheumatoid disease. Lancet. 1971;2:1012–1013.

    Article  CAS  PubMed  Google Scholar 

  93. Lowe JR, Pickup ME, Dixon JS, et al. Gamma glutamyl transpeptidase levels in arthritis: a correlation with clinical and laboratory indices of disease activity. Ann Rheum Dis. 1978;37:428–431.

    Article  CAS  PubMed  Google Scholar 

  94. Thompson PW, Houghton BJ, Clifford C, Jones DD, Whitaker KB, Moss DW. Source and significance of raised serum enzymes in rheumatoid arthritis. Quart J Med. 1990;76:869–879.

    CAS  PubMed  Google Scholar 

  95. Whaley K, Williamson J, Goudie RB, Nuki G, Buchanan WW. Liver disease in Sjögren’s syndrome and rheumatoid arthritis. Lancet. 1970;1:861–863.

    Article  CAS  PubMed  Google Scholar 

  96. Kantharia BK, Woolf AD. Raised alkaline phosphatase in rheumatoid arthritis: primary biliary cirrhosis? Br J Rheumatol. 1987;26:313–314.

    Article  CAS  PubMed  Google Scholar 

  97. Gow PJ, Fleming KA, Chapman RW. Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease? J Hepatol. 2000;34:631–635.

    Article  Google Scholar 

  98. Ruderman EM, Crawford JM, Maier A, Liu JJ, Gravallese EM, Weinblatt ME. Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis. Br J Rheumatol. 1997;36:210–213.

    Article  CAS  PubMed  Google Scholar 

  99. Leftkovits AM, Farrow U. The liver in rheumatoid arthritis. Ann Rheum Dis. 1955;14:162–168.

    Article  Google Scholar 

  100. Laffon A, Moreno A, Gutierrez-Bucero A, Ossorio C, Sabando P, Moreno-Otero R. Hepatic sinusoidal dilatation in rheumatoid arthritis. J Clin Gastroenterol. 1989;11(6):653–657.

    Article  CAS  PubMed  Google Scholar 

  101. Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613–619.

    CAS  PubMed  Google Scholar 

  102. Buskila D. Hepatitis C associated arthritis. Curr Opin Rheumatol. 2000;12:295–299.

    Article  CAS  PubMed  Google Scholar 

  103. Sene D, Ghillani-Dalbin P, Limal N, et al. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren’s syndrome. Ann Rheum Dis. 2006;65:394–397.

    Article  CAS  PubMed  Google Scholar 

  104. Morris EL, Stevens MB. Rheumatoid arthritis—a sequel to HBsAg hepatitis. Am J Med. 1978;64:859–862.

    Article  CAS  PubMed  Google Scholar 

  105. Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection. Intern Med. 1992;31:493–495.

    Article  CAS  PubMed  Google Scholar 

  106. Peterson JR, Hsu FC, Simkin PA, Wener MH. Effect of tumor necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection. Ann Rheum Dis. 2003;62:1078–1082.

    Article  CAS  PubMed  Google Scholar 

  107. Zein NN. Etanercept as an adjuvant to interferon and ribavirin in treatment-naïve patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol. 2005;42:315–322.

    Article  CAS  PubMed  Google Scholar 

  108. Nathan DM, Angus PW. Gibson PR: hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol. 2006;21:1366–1371.

    Article  CAS  PubMed  Google Scholar 

  109. Takahashi A, Yokokawa J, Iwadate H, et al. Clinical features of liver dysfunction in collagen diseases. Hepatol Res. 2010;40(11):1092–1097.

    Article  PubMed  Google Scholar 

  110. Kojima H, Uemura M, Sakurai S, et al. Clinical features of liver disturbance in rheumatoid diseases: clinicopathological study with special reference to the cause of liver disturbance. J Gastroenterol. 2002;37:617–625.

    Article  PubMed  Google Scholar 

  111. Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology. 1993;18:998–1005.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no financial interests to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ellen C. Ebert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebert, E.C., Hagspiel, K.D. Gastrointestinal and Hepatic Manifestations of Rheumatoid Arthritis. Dig Dis Sci 56, 295–302 (2011). https://doi.org/10.1007/s10620-010-1508-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1508-7

Keywords

Navigation